Posts about

DLBCL market

DLBCL Patient Insights in the US and EU5

hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies

When working on a new or existing brand within the DLBCL market it's important to have up to date...

DLBCL Treatment Performance in EU5 and US

hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies

The DLBCL market is undergoing a period of change, and the relative performance of the various...

DLBCL Market Overview

hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology

Following the release of our latest ebook, this is the first blog post in this series focusing on...

New AplusA eBook Covers the DLBCL Market

AplusA News, hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology

Introducing the latest eBook in AplusA's Hemato-Oncology series

 

DLBCL Case Study: Enhancing Patient Journey Research with Social Media Listening

hemato-oncology, DLBCL market, Social Media Listening, Syndicated Studies, Oncology

Using the example of a recent AplusA study in Diffuse Large B-Cell Lymphoma (DLBCL), we consider...

DLBCL Treatment: A Quick Overview

hemato-oncology, DLBCL market, Syndicated Studies, Oncology

DLBCL is the most common form of non-Hodgkin’s lymphoma (NHL), constituting 30% to 58% of lymphoma...